JP2012521963A5 - - Google Patents

Download PDF

Info

Publication number
JP2012521963A5
JP2012521963A5 JP2011541012A JP2011541012A JP2012521963A5 JP 2012521963 A5 JP2012521963 A5 JP 2012521963A5 JP 2011541012 A JP2011541012 A JP 2011541012A JP 2011541012 A JP2011541012 A JP 2011541012A JP 2012521963 A5 JP2012521963 A5 JP 2012521963A5
Authority
JP
Japan
Prior art keywords
lower alkyl
optionally substituted
aryl
different
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011541012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012521963A (ja
Filing date
Publication date
Priority claimed from CA2660962A external-priority patent/CA2660962A1/en
Application filed filed Critical
Publication of JP2012521963A publication Critical patent/JP2012521963A/ja
Publication of JP2012521963A5 publication Critical patent/JP2012521963A5/ja
Withdrawn legal-status Critical Current

Links

JP2011541012A 2009-03-31 2010-03-30 新規統合失調症治療用医薬組成物 Withdrawn JP2012521963A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2660962A CA2660962A1 (en) 2009-03-31 2009-03-31 Novel pharmaceutical composition for treatment of schizophrenia
CA2660962 2009-03-31
PCT/JP2010/056144 WO2010114163A1 (en) 2009-03-31 2010-03-30 Compositions comprising 2, 4, 6-triamino-1, 3, 5-triazine derivatives for treatment of schizophrenia

Publications (2)

Publication Number Publication Date
JP2012521963A JP2012521963A (ja) 2012-09-20
JP2012521963A5 true JP2012521963A5 (OSRAM) 2013-05-09

Family

ID=42269730

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011541012A Withdrawn JP2012521963A (ja) 2009-03-31 2010-03-30 新規統合失調症治療用医薬組成物

Country Status (7)

Country Link
EP (1) EP2413940A1 (OSRAM)
JP (1) JP2012521963A (OSRAM)
KR (1) KR20120004488A (OSRAM)
CN (1) CN102378630A (OSRAM)
CA (1) CA2660962A1 (OSRAM)
TW (1) TW201035081A (OSRAM)
WO (1) WO2010114163A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103351348A (zh) * 2013-07-15 2013-10-16 黄河三角洲京博化工研究院有限公司 一种2-甲胺基嘧啶盐酸盐的合成方法
KR200492485Y1 (ko) 2016-02-16 2020-10-23 주식회사 마르시끄 일회용 마스카라

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1982799A (en) 1998-01-23 1999-08-09 Yamanouchi Pharmaceutical Co., Ltd. Novel potassium channel protein
WO2002068415A1 (en) 2000-12-21 2002-09-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
MXPA04007590A (es) * 2002-02-05 2004-12-06 Yamanouchi Pharma Co Ltd Derivado de 2,4,6-triamino-1,3,5-triacina.
US8101380B2 (en) * 2007-03-26 2012-01-24 The United States Of America As Represented By The Secretary Of Health And Human Services Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

Similar Documents

Publication Publication Date Title
JP2013541514A5 (OSRAM)
JP2012184234A5 (OSRAM)
JP2013510120A5 (OSRAM)
JP2012144574A5 (OSRAM)
MX2013003938A (es) Metodos y composiciones para inhibicion de polimerasa.
JP2011513305A5 (OSRAM)
JP2016514159A5 (OSRAM)
JP2010031025A5 (OSRAM)
SG178952A1 (en) Chemical compounds
JP2008531599A5 (OSRAM)
JP2009507932A5 (OSRAM)
PL2203430T3 (pl) N-fenylo-diokso-hydropirymidyny użyteczne jako inhibitory wirusa zapalenia wątroby typu C (HCV)
EA201391629A1 (ru) Ингибиторы цсж-1r для лечения опухолей головного мозга
JP2009519243A5 (OSRAM)
JP2014533678A5 (OSRAM)
JP2013533253A5 (OSRAM)
JP2012512863A5 (OSRAM)
MX350746B (es) Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral.
RU2013140169A (ru) Противоопухолевое терапевтическое средство
JP2012508249A5 (OSRAM)
MX2012006490A (es) Inhibidores azociclicos de hidrolasa de amidas de acidos grasos.
JP2016531894A5 (OSRAM)
JP2014511366A5 (OSRAM)
WO2011047055A3 (en) Novel mek inhibitors, useful in the treatment of diseases
JP2016533368A5 (OSRAM)